XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Interim Balance Sheets (Unaudited)
€ in Thousands, $ in Thousands
Mar. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Current Assets    
Cash and cash equivalents $ 2,724 $ 2,185
Restricted cash 23 24
Investment in marketable securities (Note 5 (2)) 230 307
Accounts receivable, net of allowance for doubtful account of $43 and $42 as of March 31, 2025 and December 31, 2024, respectively. 195 143
Short term loan (Note 4) 477 234
Inventories 15 21
Prepaid expenses 408 464
Other current assets 263 26
Total Current assets 4,335 3,404
Long term prepaid expenses 196 244
Right-of-use asset arising from operating leases 29 8
Property and equipment, net 45 48
Investment in nonconsolidated affiliate (Note 3) 782 603
Long term loan (Note 5 (1)) 346 350
Solar photovoltaic joint venture project (Note 6) 1,252 808
Solar projects under development (Note 8) 380
Total assets 7,365 5,465
Current Liabilities    
Accounts payable 30 48
Current warrant liabilities 415 312
Other liabilities 531 532
Total current liabilities 976 892
Non current operating lease liabilities 15
Credit facility (Note 7) 764
Stock purchase warrants liability (Note 9(1)) 1,912
Total liabilities 3,667 892
Stockholders’ Equity    
Common stock, $ 0.0001 par value (“Common Stock”): 495,000,000 shares authorized as of March 31, 2025 and December 31, 2024; issued and outstanding 17,812,404 and 12,058,237 shares as of March 31, 2025 and December 31, 2024, respectively. 2 1
Preferred stock, $ 0.0001 par value (“Preferred Stock”): 5,000,000 shares authorized as of March 31, 2025 and December 31, 2024; issued and outstanding 0 shares as of March 31, 2025 and December 31, 2024.
Additional paid-in capital 39,714 39,327
Foreign currency translation adjustments (30) (26)
Accumulated deficit (35,746) (34,553)
Total Company’s stockholders’ equity 3,940 4,749
Non-controlling interests (242) (176)
Total stockholders’ equity 3,698 4,573
Total liabilities and stockholders’ equity $ 7,365 $ 5,465